Key Data:
Project type
Formulation facility
Estimated investment
$100 million
Output chemicals
Combination cholesterol therapy. Zocor and Ezetrol (Zetia)
Key Players:
Sponsor
MSD Technology Singapore Pte Ltd
Lead engineer / designer
Foster Wheeler
Financing
Merck Sharpe & Dohme